Related references
Note: Only part of the references are listed.Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
Mark J. Truty et al.
ANNALS OF SURGERY (2021)
Management of Locally Advanced Pancreatic Cancer Results of an International Survey of Current Practice
Bradley N. Reames et al.
ANNALS OF SURGERY (2021)
Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis
Wilson Luiz da Costa et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Neoadjuvant Treatment for Patients With Localized Pancreatic Adenocarcinoma Are We There Yet?
Wilson Luiz da Costa Jr et al.
JAMA ONCOLOGY (2020)
Hospital clinical staging accuracy for upper gastrointestinal malignancy
Wilson Luiz da Costa et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment
Stijn van Roessel et al.
JAMA ONCOLOGY (2020)
Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy
Katherine A. Baugh et al.
SURGERY (2019)
Nodal downstaging as a treatment goal for node-positive pancreatic cancer
Jorge I. Portuondo et al.
SURGERY (2019)
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A Prospective, Open-Label, Multicenter Phase 2 Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma
Hidetoshi Eguchi et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer
Sung Jun Ma et al.
JAMA NETWORK OPEN (2019)
Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
E. Versteijne et al.
BRITISH JOURNAL OF SURGERY (2018)
Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy
Marc Zins et al.
RADIOLOGY (2018)
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2018)
Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18243 patients
Linda M. Youngwirth et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
Value of lymph node positivity in treatment planning for early stage pancreatic cancer
Hop S. Tran Cao et al.
SURGERY (2017)
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M. Cloyd et al.
JAMA SURGERY (2017)
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
Matthew H. G. Katz et al.
BMC CANCER (2017)
Presurgical Evaluation of Pancreatic Cancer: A Comprehensive Imaging Comparison of CT Versus MRI
Fang-Ming Chen et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2016)
Pledging to Eliminate Low-Volume Surgery
David R. Urbach
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma
Wenchuan Wu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer Registries
Catherine C. Lerro et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Share Paper
